Business Combinations and Contingent Consideration Liabilities - Additional Information (Details)
|
|
6 Months Ended |
Feb. 08, 2023 |
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
| Business Combination [Line Items] |
|
|
|
| Fair value |
|
$ 152,000
|
|
| Chronix [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Fair value |
|
$ 3,500,000
|
|
| Merger Agreement [Member] | Chronix Equity [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Earnout percentage on collections for sales |
10.00%
|
|
|
| Gross proceeds percentage |
5.00%
|
|
|
| Insight Genetics Inc [Member] | Discount rate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
0.138
|
|
| Insight Genetics Inc [Member] | Maximum [Member] | Discount rate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
|
0.129
|
| Insight Genetics Inc [Member] | Maximum [Member] | Management probability estimate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
0.50
|
0.50
|
| Insight Genetics Inc [Member] | Maximum [Member] | Expected term [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, milestone payment |
|
2 years 4 months 24 days
|
7 years 3 months 18 days
|
| Insight Genetics Inc [Member] | Minimum [Member] | Discount rate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
|
0.126
|
| Insight Genetics Inc [Member] | Minimum [Member] | Management probability estimate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
0.25
|
0.25
|
| Insight Genetics Inc [Member] | Minimum [Member] | Expected term [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, milestone payment |
|
2 years 2 months 12 days
|
1 year 8 months 12 days
|
| Insight Genetics Inc [Member] | Valuation Technique, Discounted Cash Flow [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Unobservable Measurement Input, Uncertainty, Description |
|
The significant unobservable inputs used in IGI’s contingent consideration valuation on June 30, 2026, included: (i) a discount period, based on the expected Milestone payment dates, ranging from 2.2 years to 2.4 years, (ii) a discount rate of 13.8%, and (iii) a management probability estimate of 25% to 50%. The significant unobservable inputs used in IGI’s contingent consideration valuation on June 30, 2025, included: (i) a discount period, based on the expected Milestone payment dates, ranging from 1.7 years to 7.3 years, (ii) a discount rate of 12.6% to 12.9%, and (iii) a management probability estimate of 25% to 50%.
|
|
| Chronix Merger [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Deferred tax assets related to contingent consideration |
|
$ 0
|
$ 0
|
| Chronix Merger [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Payout percentage |
|
10.00%
|
10.00%
|
| Chronix Merger [Member] | Maximum [Member] | Discount rate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
0.141
|
0.132
|
| Chronix Merger [Member] | Maximum [Member] | Expected term [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, related patent expiration range term |
|
9 years 2 months 12 days
|
10 years 2 months 12 days
|
| Chronix Merger [Member] | Minimum [Member] | Discount rate [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, measurement input |
|
0.136
|
0.126
|
| Chronix Merger [Member] | Minimum [Member] | Expected term [Member] | Level 3 [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Business combination, contingent consideration, liability, related patent expiration range term |
|
8 years 3 months 18 days
|
9 years 3 months 18 days
|
| Chronix Merger [Member] | Valuation Technique, Discounted Cash Flow [Member] |
|
|
|
| Business Combination [Line Items] |
|
|
|
| Unobservable Measurement Input, Uncertainty, Description |
|
The significant unobservable inputs used in Chronix’s contingent consideration valuation on June 30, 2026, included: (i) a discount period, based on the related patent expiration dates, ranging from 8.3 years to 9.2 years, (ii) a discount rate of 13.6% to 14.1%, and (iii) a payout percentage of 10% based on the earnout provision. The significant unobservable inputs used in Chronix’s contingent consideration valuation on June 30, 2025, included: (i) a discount period, based on the related patent expiration dates, ranging from 9.3 years to 10.2 years, (ii) a discount rate of 12.6% to 13.2%, and (iii) a payout percentage of 10% based on the earnout provision.
|
|